On December 17, 2020, the Federal Trade Commission (FTC or the Commission) announced that it has taken action against six cannabidiol (CBD) brands for allegedly making a wide range of unsubstantiated claims about the ability of the firms’ products to treat serious health conditions (e.g., cancer,…
